跳至主要内容
临床试验/NCT03628430
NCT03628430已完成不适用

Effect of Buffered Lidocaine With Epinephrine in Local Anesthesia During Subcutaneous Implantable Venous Access Devices Insertion: Double Blind Randomized Study.

Faculty of Medicine, Sousse0 个研究点目标入组 120 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
主要终点
T4 pain intensity

研究概览

简要总结

Subcutaneous implantable venous access devices are routinely implanted under local anesthesia. However, patients complain of pain during the injection of local anesthesia. The aim of this study was to evaluate the effectiveness of sodium bicarbonate-buffered lidocaine with epinephrine on reducing pain and patients' satisfaction during subcutaneous implantable venous access devices insertion.

A prospective double-blind study was conducted over a period of 6 months (1st January 2017 to 30th June 2017). Patients were randomized to receive either buffered (PH= 7.33) or plane lidocaine (PH= 3.50). The same operator made all insertions using a standard technique. Pain at five procedural steps (local anesthetic infiltration, central vein cannulation, skin incision, deep tissue dissection and pocket formation, and skin closure) and satisfaction were evaluated on a VAS score (0-100 mm). Secondary outcomes were sensory block onset time using pinprick test and patients' satisfaction.

详细描述

This prospective, randomized, controlled, double-blinded study was carried out in the Anesthesia and Resuscitation Department of Farhat Hached University Hospital of Sousse over a period of 6 months (1st January 2017 to 30th June 2017). Ethical approval was obtained from the institution's Research Ethics Board. Written informed consent was obtained from each patient by the investigators before entering this study. Outpatients, aged over 18 years, scheduled for Porta-Cath (PAC) insertion under local anesthesia were included.

Apart from the usual contraindications to PAC insertion, pregnant women, patients with a known allergy to study drugs, patients chronically using opioids or benzodiazepine for cancer or chronic pain, patients with history of thoracic or cervico-facial radiotherapy or those with severe cardiovascular and respiratory compromise or having a neuropathy were excluded from the study.

The study subjects randomly received, in a double blind manner (using computer-generated allocation numbers sealed in brown envelopes), one of two local anesthetic solutions. The pH adjusted group (group A) received 5 mL of 4.2 % sodium bicarbonate added to 10 mL of 2% lidocaine with epinephrine 0.005mg/ml (Lidocaine adrenaline; Aguettant, France) and the control group (group C) received 5 mL of 0.9% NaCl added to 10 mL of 2% lidocaine with epinephrine 0.005mg/ml (Lidocaine adrenaline; Aguettant, France).

Local anesthetic solutions were freshly prepared by a member of the anesthesia team and balanced at room temperature 30 minute prior to the procedure, whereas the anesthetist in charge of the patient was unaware of the prepared solution. The pH values of the final formulations have been measured using a pH-meter (PH-meter/millivoltmeter 3510 JENWAY) at the beginning of the study; it was 3.5 in the control group and 7.33 in the study group.

Routine monitoring included heart rate, blood pressure, oxyhemoglobin saturation, and respiratory rate were applied at arrival in the operating room. The process has been carried out in conditions of surgical asepsis. The preparation of the insertion area of the PAC included a prerequisite depilation, a cleaning of the area, rinsing, drying, an application of an antiseptic and then the setting of sterile drapes widely extending beyond the catheterization area. No preoperative sedation was administered. There was no pretreatment of the skin with any type of topical anesthetic or pain reducing technique before the injection of the anesthetic mixture.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Outpatients, aged over 18 years, scheduled for PAC placement under local anesthesia

排除标准

  • usual contraindications to PAC insertion,
  • pregnant women,
  • patients with a known allergy to study drugs,
  • patients chronically using opioids or benzodiazepine for cancer or chronic pain,
  • patients with history of thoracic or cervico-facial radiotherapy
  • patients with severe cardiovascular and respiratory compromise
  • patients having a neuropathy

结局指标

主要结局

T4 pain intensity

时间窗: Immediately after deep tissue dissection and pocket formation,

pain intensity assessed immediately after deep tissue dissection and pocket formation, by a 100 mm visual analog scale (VAS) ranging from 0 (no pain) to 100 (the worst possible pain).

T3 pain intensity

时间窗: Immediately after skin incision,

pain intensity assessed immediately after skin incision, by a 100 mm visual analog scale (VAS) ranging from 0 (no pain) to 100 (the worst possible pain).

T2 pain intensity

时间窗: Immediately after central vein cannulation

pain intensity assessed immediately after central vein cannulation, by a 100 mm visual analog scale (VAS) ranging from 0 (no pain) to 100 (the worst possible pain).

T1 pain intensity

时间窗: Immediately after local anesthetic infiltration

pain intensity assessed immediately after local anesthetic infiltration, by a 100 mm visual analog scale (VAS) ranging from 0 (no pain) to 100 (the worst possible pain).

T5 pain intensity

时间窗: Immediately after skin closure.

pain intensity assessed immediately after skin closure, by a 100 mm visual analog scale (VAS) ranging from 0 (no pain) to 100 (the worst possible pain).

次要结局

  • sensory block onset time(up to one hour after the intervention)
  • patients' satisfaction.(Immediately after the intervention)

研究者

发起方
Faculty of Medicine, Sousse
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Kahloul

principal investigator

Faculty of Medicine, Sousse

相似试验